Palisade Bio, Inc. (PALI) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 130.82M |
| Enterprise Value | -2.49M |
| P/E Ratio | -5.28 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 407.79 |
| Price/Book Ratio | 2.21 |
| Enterprise/Revenue | 180.57 |
| Enterprise/EBITDA | -2.01 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -87.39 |
| Operating Margin | -96.25 |
| Return On Assets | -0.37 |
| Return On Equity | -0.36 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -16.77M |
| Net Income | -16.78M |
| Diluted EPS | -0.3 |
| Total Cash | 113.61M |
| Total Cash/Share | 0.54 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 20.16 |
| Book Value Per Share | 0.53 |
| 52-Week Change | -35.71 |
| 52-Week High | 2.86 |
| 52-Week Low | 1.08 |
| Moving Average 50 Days | 1.53 |
| Moving Average 200 Days | 1.83 |
| Average Volume | 3.1M |
| Shares Outstanding | 174.27M |
| % Held by Institutions | 82.23 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | April 08, 2024 |